PharmaCyte Biotech Inc (PMCB)

[Triple9]

No one can accurately predict what will happen here, but there are a few things we can keep in mind.

$PMCB owns 14.5% of Austrianova. More importantly, Principals in Austrianova have significant shares in $PMCB. $PMCB also just gained Right of First Refusal for any potential deal Austrianova brokered. We have our 2016 Binding Memo of Understanding that states PMCB will develop CiaB for cancers and that the two will share net revenues from any drugs developed by PMCB. We also have exclusive rights to diabetes development for CiaB. The two entities are strongly linked and the deals and agreements in place are for revenue sharing so both companies profit.

The other side of the equation is entirely unknown. Would any potential partner want to pay royalties or would the partner eventually want to own the technology outright?

But one thing at a time. Let's get that IND submitted!